{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:39:30Z","timestamp":1778873970542,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203792"],"award-info":[{"award-number":["82203792"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012247","name":"Program of Shanghai Academic\/Technology Research Leader","doi-asserted-by":"crossref","award":["22XD1400300"],"award-info":[{"award-number":["22XD1400300"]}],"id":[{"id":"10.13039\/501100012247","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Updates Surg"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s13304-025-02189-y","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T14:22:29Z","timestamp":1743776549000},"page":"675-684","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Genetic predictors of postoperative recurrence in node-negative intrahepatic cholangiocarcinoma"],"prefix":"10.1007","volume":"77","author":[{"given":"Bo","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu-Yu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Tian","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Wei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0952-9990","authenticated-orcid":false,"given":"Jin-Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,2]]},"reference":[{"issue":"2","key":"2189_CR1","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3322\/caac.21759","volume":"73","author":"D Moris","year":"2022","unstructured":"Moris D, Palta M, Kim C, Allen PJ, Morse MA, Lidsky ME (2022) Advances in the treatment of intrahepatic cholangiocarcinoma: an overview of the current and future therapeutic landscape for clinicians. CA Cancer J Clin 73(2):198\u2013222","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"2189_CR2","doi-asserted-by":"publisher","first-page":"301","DOI":"10.21037\/hbsn.2019.01.15","volume":"8","author":"M Raoof","year":"2019","unstructured":"Raoof M, Singh G (2019) Rising trends in intrahepatic cholangiocarcinoma incidence and mortality: getting at the root cause. Hepatobiliary Surg Nutr 8(3):301\u2013303","journal-title":"Hepatobiliary Surg Nutr"},{"key":"2189_CR3","doi-asserted-by":"crossref","unstructured":"Mazzaferro V, Gorgen A, Roayaie S, Droz Dit Busset M, Sapisochin G. Liver resection and transplantation for intrahepatic cholangiocarcinoma. J Hepatol. 2020;72(2):364\u2013377.","DOI":"10.1016\/j.jhep.2019.11.020"},{"key":"2189_CR4","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.surg.2012.12.005","volume":"153","author":"O Hyder","year":"2013","unstructured":"Hyder O, Hatzaras I, Sotiropoulos GC et al (2013) Recurrence after operative management of intrahepatic cholangiocarcinoma. Surgery 153:811\u2013818","journal-title":"Surgery"},{"issue":"1","key":"2189_CR5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1245\/s10434-015-4642-9","volume":"23","author":"G Spolverato","year":"2016","unstructured":"Spolverato G, Kim Y, Alexandrescu S et al (2016) Management and Outcomes of Patients with Recurrent Intrahepatic Cholangiocarcinoma Following Previous Curative-Intent Surgical Resection. Ann Surg Oncol 23(1):235\u2013243","journal-title":"Ann Surg Oncol"},{"issue":"31","key":"2189_CR6","doi-asserted-by":"publisher","first-page":"3667","DOI":"10.1200\/JCO.22.01213","volume":"40","author":"J Edeline","year":"2022","unstructured":"Edeline J, Malka D (2022) Capecitabine: still a standard option in the adjuvant setting of biliary tract cancer? J Clin Oncol 40(31):3667\u20133668","journal-title":"J Clin Oncol"},{"issue":"12","key":"2189_CR7","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1002\/bjs.8953","volume":"99","author":"L Sulpice","year":"2012","unstructured":"Sulpice L, Rayar M, Boucher E, Pracht M, Meunier B, Boudjema K (2012) Treatment of recurrent intrahepatic cholangiocarcinoma. Br J Surg 99(12):1711\u20131717","journal-title":"Br J Surg"},{"issue":"8","key":"2189_CR8","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1245\/s10434-019-07353-4","volume":"26","author":"LS Hu","year":"2019","unstructured":"Hu LS, Zhang XF, Weiss M et al (2019) Recurrence patterns and timing courses following curative-intent resection for intrahepatic cholangiocarcinoma. Ann Surg Oncol 26(8):2549\u20132557","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"2189_CR9","doi-asserted-by":"publisher","first-page":"464","DOI":"10.21037\/hbsn.2020.01.07","volume":"10","author":"S Jeong","year":"2021","unstructured":"Jeong S, Luo G, Gao Q et al (2021) A combined Cox and logistic model provides accurate predictive performance in estimation of time-dependent probabilities for recurrence of intrahepatic cholangiocarcinoma after resection. Hepatobiliary Surg Nutr 10(4):464\u2013475","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"3","key":"2189_CR10","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1245\/s10434-022-12463-7","volume":"30","author":"L Alaimo","year":"2023","unstructured":"Alaimo L, Moazzam Z, Brown ZJ et al (2023) Application of hazard function to investigate recurrence of intrahepatic cholangiocarcinoma after curative-intent liver resection: a novel approach to characterize recurrence. Ann Surg Oncol 30(3):1340\u20131349","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"2189_CR11","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1245\/s10434-009-0631-1","volume":"16","author":"SB Choi","year":"2009","unstructured":"Choi SB, Kim KS, Choi JY, Park SW, Choi JS, Lee WJ, Chung JB (2009) The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival. Ann Surg Oncol 16(11):3048\u20133056","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"2189_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.hpb.2015.07.006","volume":"18","author":"Z Jutric","year":"2016","unstructured":"Jutric Z, Johnston WC, Hoen HM, Newell PH, Cassera MA, Hammill CW, Wolf RF, Hansen PD (2016) Impact of lymph node status in patients with intrahepatic cholangiocarcinoma treated by major hepatectomy: a review of the National Cancer Database. HPB (Oxford) 18(1):79\u201387","journal-title":"HPB (Oxford)"},{"issue":"2","key":"2189_CR13","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1245\/s10434-021-10820-6","volume":"29","author":"M Kubo","year":"2022","unstructured":"Kubo M, Kobayashi S, Gotoh K et al (2022) Preoperative FDG-positive lymph nodes predict the postoperative prognosis in resectable biliary tract cancers. Ann Surg Oncol 29(2):935\u2013944","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"2189_CR14","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.surg.2021.12.026","volume":"172","author":"SH Kim","year":"2022","unstructured":"Kim SH, Han DH, Choi GH, Choi JS, Kim KS (2022) Prognostic impact of the metastatic lymph node number in intrahepatic cholangiocarcinoma. Surgery 172(1):177\u2013183","journal-title":"Surgery"},{"issue":"1","key":"2189_CR15","doi-asserted-by":"publisher","first-page":"260","DOI":"10.7150\/thno.63417","volume":"12","author":"XY Wang","year":"2022","unstructured":"Wang XY, Zhu WW, Wang Z et al (2022) Driver mutations of intrahepatic cholangiocarcinoma shape clinically relevant genomic clusters with distinct molecular features and therapeutic vulnerabilities. Theranostics 12(1):260\u2013276","journal-title":"Theranostics"},{"key":"2189_CR16","doi-asserted-by":"crossref","unstructured":"Wang XY, Zhu WW, Lu L, et al. Development and validation of a mutation-annotated prognostic score (MAPS) for intrahepatic cholangiocarcinoma after resection: A retrospective cohort study. Int J Surg. 2023. Epub ahead of print.","DOI":"10.1097\/JS9.0000000000000636"},{"issue":"3","key":"2189_CR17","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1002\/hep.31829","volume":"74","author":"T Boerner","year":"2021","unstructured":"Boerner T, Drill E, Pak LM et al (2021) Genetic determinants of outcome in intrahepatic cholangiocarcinoma. Hepatology 74(3):1429\u20131444","journal-title":"Hepatology"},{"key":"2189_CR18","doi-asserted-by":"publisher","first-page":"5696","DOI":"10.1038\/ncomms6696","volume":"5","author":"S Zou","year":"2014","unstructured":"Zou S, Li J, Zhou H et al (2014) Mutational landscape of intrahepatic cholangiocarcinoma. Nat Commun 5:5696","journal-title":"Nat Commun"},{"key":"2189_CR19","doi-asserted-by":"publisher","first-page":"6120","DOI":"10.1038\/ncomms7120","volume":"6","author":"A Fujimoto","year":"2015","unstructured":"Fujimoto A, Furuta M, Shiraishi Y et al (2015) Whole-genome mutational landscape of liver cancers displaying biliary phenotype reveals hepatitis impact and molecular diversity. Nat Commun 6:6120","journal-title":"Nat Commun"},{"issue":"9","key":"2189_CR20","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/ng.3375","volume":"47","author":"H Nakamura","year":"2015","unstructured":"Nakamura H, Arai Y, Totoki Y et al (2015) Genomic spectra of biliary tract cancer. Nat Genet 47(9):1003\u20131010","journal-title":"Nat Genet"},{"issue":"10","key":"2189_CR21","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1002\/ijc.31979","volume":"144","author":"Y Sheng","year":"2019","unstructured":"Sheng Y, Wei J, Zhang Y et al (2019) Mutated EPHA2 is a target for combating lymphatic metastasis in intrahepatic cholangiocarcinoma. Int J Cancer 144(10):2440\u20132452","journal-title":"Int J Cancer"},{"issue":"10","key":"2189_CR22","doi-asserted-by":"publisher","first-page":"4585","DOI":"10.7150\/thno.56539","volume":"11","author":"J Lin","year":"2021","unstructured":"Lin J, Cao Y, Yang X et al (2021) Mutational spectrum and precision oncology for biliary tract carcinoma. Theranostics 11(10):4585\u20134598","journal-title":"Theranostics"},{"issue":"Suppl 3","key":"2189_CR23","doi-asserted-by":"publisher","first-page":"S675","DOI":"10.1245\/s10434-012-2224-7","volume":"19","author":"TC Chen","year":"2012","unstructured":"Chen TC, Jan YY, Yeh TS (2012) K-ras mutation is strongly associated with perineural invasion and represents an independent prognostic factor of intrahepatic cholangiocarcinoma after hepatectomy. Ann Surg Oncol 19(Suppl 3):S675-681","journal-title":"Ann Surg Oncol"},{"issue":"24","key":"2189_CR24","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1002\/cncr.30254","volume":"122","author":"M Javle","year":"2016","unstructured":"Javle M, Bekaii-Saab T, Jain A et al (2016) Biliary cancer: Utility of next-generation sequencing for clinical management. Cancer 122(24):3838\u20133847","journal-title":"Cancer"},{"issue":"5","key":"2189_CR25","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1245\/s10434-015-5046-6","volume":"23","author":"A Ruzzenente","year":"2016","unstructured":"Ruzzenente A, Fassan M, Conci S et al (2016) Cholangiocarcinoma heterogeneity revealed by multigene mutational profiling: clinical and prognostic relevance in surgically resected patients. Ann Surg Oncol 23(5):1699\u20131707","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"2189_CR26","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/jso.25303","volume":"119","author":"J Huang","year":"2019","unstructured":"Huang J, Wang X, Zhu Y et al (2019) Specific prognostic factors in hepatitis B virus-related and non-hepatitis B virus-related intrahepatic cholangiocarcinoma after macroscopic curative resection. J Surg Oncol 119(1):40\u201346","journal-title":"J Surg Oncol"},{"key":"2189_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ejca.2019.07.022","volume":"120","author":"H Chae","year":"2019","unstructured":"Chae H, Kim D, Yoo C et al (2019) Therapeutic relevance of targeted sequencing in management of patients with advanced biliary tract cancer: DNA damage repair gene mutations as a predictive biomarker. Eur J Cancer 120:31\u201339","journal-title":"Eur J Cancer"},{"issue":"6","key":"2189_CR28","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1158\/0008-5472.CAN-11-3596","volume":"72","author":"MR O'Dell","year":"2012","unstructured":"O\u2019Dell MR, Huang JL, Whitney-Miller CL et al (2012) Kras(G12D) and p53 mutation cause primary intrahepatic cholangiocarcinoma. Cancer Res 72(6):1557\u20131567","journal-title":"Cancer Res"},{"issue":"16","key":"2189_CR29","doi-asserted-by":"publisher","first-page":"4445","DOI":"10.1158\/0008-5472.CAN-17-1123","volume":"78","author":"MA Hill","year":"2018","unstructured":"Hill MA, Alexander WB, Guo B et al (2018) Kras and Tp53 Mutations Cause Cholangiocyte- and Hepatocyte-Derived Cholangiocarcinoma. Cancer Res 78(16):4445\u20134451","journal-title":"Cancer Res"},{"issue":"1","key":"2189_CR30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/bjs.11443","volume":"107","author":"J Datta","year":"2020","unstructured":"Datta J, Da Silva EM, Kandoth C et al (2020) Poor survival after resection of early gastric cancer: extremes-of-survivorship analysis reveal distinct genomic profile. Br J Surg 107(1):14\u201319","journal-title":"Br J Surg"},{"issue":"5","key":"2189_CR31","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1158\/1078-0432.CCR-19-2390","volume":"26","author":"J Datta","year":"2020","unstructured":"Datta J, Smith JJ, Chatila WK et al (2020) Coaltered Ras\/B-raf and TP53 is associated with extremes of survivorship and distinct patterns of metastasis in patients with metastatic colorectal cancer. Clin Cancer Res 26(5):1077\u20131085","journal-title":"Clin Cancer Res"},{"issue":"7","key":"2189_CR32","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1002\/bjs.10676","volume":"105","author":"XF Zhang","year":"2018","unstructured":"Zhang XF, Beal EW, Bagante F et al (2018) Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent. Br J Surg 105(7):848\u2013856","journal-title":"Br J Surg"},{"issue":"1","key":"2189_CR33","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40644-019-0234-4","volume":"19","author":"L Zhao","year":"2019","unstructured":"Zhao L, Ma X, Liang M et al (2019) Prediction for early recurrence of intrahepatic mass-forming cholangiocarcinoma: quantitative magnetic resonance imaging combined with prognostic immunohistochemical markers. Cancer Imaging 19(1):49","journal-title":"Cancer Imaging"},{"issue":"10","key":"2189_CR34","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1007\/s00268-022-06655-1","volume":"46","author":"A Nassar","year":"2022","unstructured":"Nassar A, Tzedakis S, Sindayigaya R et al (2022) Factors of early recurrence after resection for intrahepatic cholangiocarcinoma. World J Surg 46(10):2459\u20132467","journal-title":"World J Surg"},{"issue":"7","key":"2189_CR35","doi-asserted-by":"publisher","first-page":"4337","DOI":"10.1245\/s10434-022-11463-x","volume":"29","author":"WJ Choi","year":"2022","unstructured":"Choi WJ, Williams PJ, Claasen MPAW et al (2022) Systematic review and meta-analysis of prognostic factors for early recurrence in intrahepatic cholangiocarcinoma after curative-intent resection. Ann Surg Oncol 29(7):4337\u20134353","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"2189_CR36","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1001\/jamasurg.2020.1973","volume":"155","author":"DI Tsilimigras","year":"2020","unstructured":"Tsilimigras DI, Sahara K, Wu L et al (2020) Very early recurrence after liver resection for intrahepatic cholangiocarcinoma: considering alternative treatment approaches. JAMA Surg 155(9):823\u2013831","journal-title":"JAMA Surg"},{"issue":"1","key":"2189_CR37","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s13304-020-00718-5","volume":"72","author":"S Conci","year":"2020","unstructured":"Conci S, Ruzzenente A, Simbolo M et al (2020) Multigene mutational profiling of biliary tract cancer is related to the pattern of recurrence in surgically resected patients. Updates Surg 72(1):119\u2013128","journal-title":"Updates Surg"},{"issue":"1","key":"2189_CR38","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/SLA.0b013e3181e462e6","volume":"252","author":"G Ercolani","year":"2010","unstructured":"Ercolani G, Vetrone G, Grazi GL et al (2010) Intrahepatic cholangiocarcinoma: primary liver resection and aggressive multimodal treatment of recurrence significantly prolong survival. Ann Surg 252(1):107\u2013114","journal-title":"Ann Surg"},{"key":"2189_CR39","doi-asserted-by":"crossref","unstructured":"Ohira M, Kobayashi T, Hashimoto M, et al. Prognostic factors in patients with recurrent intrahepatic cholangiocarcinoma after curative resection: A retrospective cohort study. Int J Surg. 2018;54(PA):156\u2013162.","DOI":"10.1016\/j.ijsu.2018.04.058"},{"issue":"1","key":"2189_CR40","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jhep.2023.03.010","volume":"79","author":"European Association for the Study of the Liver","year":"2023","unstructured":"European Association for the Study of the Liver (2023) EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma. J Hepatol 79(1):181\u2013208","journal-title":"J Hepatol"}],"container-title":["Updates in Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-025-02189-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13304-025-02189-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-025-02189-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T14:42:01Z","timestamp":1751553721000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13304-025-02189-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,2]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["2189"],"URL":"https:\/\/doi.org\/10.1007\/s13304-025-02189-y","relation":{},"ISSN":["2038-131X","2038-3312"],"issn-type":[{"value":"2038-131X","type":"print"},{"value":"2038-3312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,2]]},"assertion":[{"value":"21 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics Committee of Huashan Hospital, Fudan University (KY2022-945).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"This study was approved by the Ethics Committee of Huashan Hospital, Fudan University (Approval Number: KY2022-945). All participants provided and signed written informed consent, and all procedures followed the Declaration of Helsinki. This study did not involve animal research.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals, and Informed consent"}}]}}